Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 64,850 | 59,757 | 54,659 | 55,503 | 48,524 |
| Cost of Goods | 276 | 346 | 216 | 639 | 74 |
| Gross Profit | 64,574 | 59,411 | 54,443 | 54,863 | 48,450 |
| Operating Expenses | 78,994 | 73,514 | 69,355 | 83,614 | 41,255 |
| Operating Income | -14,144 | -13,757 | -14,696 | -28,112 | 7,269 |
| Interest Expense | 1,321 | 1,274 | 1,250 | -236 | 2,102 |
| Other Income | 16,196 | -1,792 | -3,210 | 15,369 | 703 |
| Pre-tax Income | 731 | -16,823 | -19,156 | -12,506 | 5,870 |
| Income Tax | -175 | 191 | 293 | 18,046 | -1,465 |
| Net Income Continuous | 906 | -17,014 | -19,449 | -30,553 | 7,335 |
| Net Income | $906 | $-17,014 | $-19,449 | $-30,553 | $7,335 |
| EPS Basic Total Ops | 0.02 | -0.35 | -0.40 | -0.63 | 0.15 |
| EPS Basic Continuous Ops | 0.02 | -0.35 | -0.40 | -0.64 | 0.16 |
| EPS Diluted Total Ops | 0.02 | -0.35 | -0.40 | -0.62 | 0.14 |
| EPS Diluted Continuous Ops | 0.02 | -0.35 | -0.40 | -0.62 | 0.14 |
| EBITDA(a) | $-13,067 | $-12,728 | $-13,744 | $-28,423 | $8,751 |